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AbstrAct
In the photothermal treatments (PTs) of tumor, the localization of a high 
number of near-infrared (NIR) absorbing gold nanoparticles in the tumor mass is 
still a challenging issue. Here, we propose a promising strategy to deliver therapeutic 
chitosan-coated gold nanoparticles to tumor cells as hidden cargo of Endothelial 
Colony Forming Cells (ECFCs) endowed with an innate tumor-tropism. Remarkably, 
ECFC gold enrichement doesn’t affect cell viability and preserves the endothelial 
lineage characteristics such as capillary morphogenesis and cell migration. We 
demonstrate that heavily Au-doped ECFCs are able to efficiently warm up the tumor 
environment, and kill the cancer cells via hyperthermic heating both in vitro as well 
as in vivo. Thus, we show an excellent thermotransductive property of gold enriched 
ECFCs and their capability to kill melanoma cells at moderate NIR light intensities.
IntroductIon
Cell-based therapies, namely treatments in which 
stem or progenitor cells are induced to home within 
damaged or cancer tissues, and nanomaterial-mediated 
photothermal ablation using near-infrared (NIR) light have 
significantly advanced and are poised to become a major 
pillar of modern medicine.
In the last decade, cell-mediated delivery has been 
widely used in the therapy of many kinds of tumors, 
including glioma, head and neck carcinoma and breast 
cancer [1, 2]. This method appears to be suitable for all 
kinds of tumor [1], but in reality not all cells can be used 
to specifically deliver therapeutic payloads. For instance, 
the shuttle cells should have a high loading capacity for 
the drugs or nanomaterials and innate tumor tropism [3, 4].
Gold nanoparticles (GNPs) are promising therapeutic 
tools for the treatment of cancer due to their non-cytotoxic 
nature, reliable synthesis and functionalization and, 
most importantly, their tunable plasmonic properties. 
This allows tailoring gold nanostructures to produce 
local heating when exposed to near-infrared (NIR) light 
[5–9]. Although multifunctional nanoparticles have 
been used as photothermal agents in cancer treatment, 
at the current stage of development the majority of the 
administered nanoparticles end up in healthy organs 
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and tissues, even with the assistance of active targeting 
[10–12]. Moreover particles with longer circulation times, 
and hence greater ability to target the site of interest, 
are more exposed to clearance by macrophages [13]. 
Furthermore, virtually all molecular or nanoparticle-
based therapies are inaccessible to the hypoxic areas of 
tumors that lack blood flow, thus limiting the treatment 
efficacy [14]. Moreover, it has been reported the effect of 
PEGylated GNP on deformability and oxygen-delivering 
ability of the primary functions of erythrocytes [15]. 
Direct intratumoral injection can be used to circumvent 
the inefficiency and off-target deposition [16, 17], however 
the injected nanoparticles generally remain at the site 
of injection and are unable to penetrate the tumor mass 
leading to incomplete ablation and disease recurrence.
In the light of these considerations, the current 
approach to improve delivery of nanodrugs is based 
on exploiting live cells with natural tumor-homing 
ability, such as T-cells, monocytes/macrophages and 
mesenchymal stem cells (MSCs) [18–20]. 
In this work, we propose alternative NIR-sensitive, 
tumor tropic cellular vectors, Endothelial Colony Forming 
Cells (ECFCs), enriched with chitosan-coated Au 
nanoparticles. ECFCs cells are a sub-class of Endothelial 
Progenitor Cells (EPC), that, thanks to their excellent 
tumor-tropism, have been elicited as ideal candidates 
for cell-based anti-cancer treatments [21]. Recently, 
this conclusion was supported by direct observation 
that intravenously injected, 111In-oxine labeled ECFCs 
homed selectively in human melanomas, transplanted in 
nude mice, by exploiting the CXCR4/SDF1 axis [22]. 
Alongside, these cells can be readily procured from 
autologous donors, are easily expanded and modified 
ex vivo [23], limiting possible issues of intolerance or 
hypersensitivity. Moreover, considering their unique, 
strategic position at the interface between plasma and 
interstitial fluid, endothelial cells and their progenitors 
are endowed with the cellular machinery to perform 
transcytosis, which implies transporting plasma molecules 
to the subjacent cells and tissues in vivo, whereas in vitro 
the transcytotic cargo vesicles are retained within the 
cells preventing exocytosis of their content. Finally, being 
natural “moving gears” per se these cells with tumor-
tropic features are able to deliver their hidden cargo, 
which consists of chitosan-coated Au nanoparticles, to the 
tumor. Chitosan, a highly biocompatible polysaccharide, 
gives to the nanoparticles an overall positive external 
electric charge that, other than stabilizing the colloidal 
solution, promotes two beneficial effects: 1) as the cell 
membranes have an external negative charge, an improved 
enrichment is expected as a consequence of the stronger 
electrically-induced nanoparticle-cell interaction [24]; 2) 
upon massive loading, chitosan-capped nanoparticles 
are able to bypass the rapid lysosomal exocitic pathway 
and remain in the cytoplasm more than 10 days after 
the enrichment stage. We found that ECFCs exhibit a 
remarkable avidity of these Au nanoparticles, but at the 
same time the phenotypical properties of ECFCs are 
substantially unchanged. We simulated the laser treatment 
in vitro by irradiating a liquid mixture of human A375 
melanoma cells and enriched ECFCs, a model that 
realistically renders the volumetric heat diffusion and the 
subsequent heat absorption by nearby cells. We found, 
in vitro a massive tumor cells death upon laser irradiation 
at moderate intensity. Nonetheless, in vivo photothermal 
experiment of gold-enriched ECFCs directly perfused in a 
tumor mass, showed a considerable necrotization of tumor 
tissue. 
Melanoma is a worldwide increasing pathology, 
whose incidence in Caucasian population is increasing 3% 
on a yearly basis. In spite of recent advances in melanoma 
treatment the patient prognosis is still very poor because 
of its high multidrug resistance, easy to relapse and low 
survival rate. With the development of nanotechnology, 
the use of nano-objects is widely expected to change the 
landscape of melanoma therapy in the near future.
rEsuLts
nanoparticles characterization and EcFc 
enrichment
GNPs were synthesized (~1 hour) by one-step 
reaction without the assistance of additional templates, 
capping agents or seed assembly. The product (Aumix) 
consists of nanoparticles with different shape and size, 
including small spherical colloid gold particles (diameter 
< 5 nm) and aspherical gold crystals [25]. Figure 1A shows 
a typical TEM image of as-produced Aumix. A typical UV-
Vis extinction spectrum of the colloidal solution is reported 
in Figure 1B, with two absorption peaks due to the surface 
plasmon resonance. The peak centered at around 520 nm 
is mainly due to the characteristic plasmonic fingerprint 
of the spherical colloidal nanoparticles and the second 
component is at NIR band, which is attributed to the 
dipolar SPR absorption from the anisotropic GNPs [25, 26]. 
The NIR-band could in principle be enhanced by removing 
the spherical particles [24, 25], but the modest heating 
enhancement achievable, later on described, doesn’t seem to 
justify the adoption of the more complex production route.
The surface modification obtained after chitosan 
addition was confirmed by a red-shift of the absorbance 
spectrum (Figure 1B) and a change of the colloidal 
z-potential (Figure 1C), that shifted from −40 mV for the 
as-prepared colloidal dispersion to +32 mV. Even though 
the as-produced colloidal solutions remained stable 
per se for a variable period of time (from a few 
days to a week), the addition of chitosan on Aumix 
(from now on ChAumix) guaranteed a longer-
term stability, assessed by recording  the plasmonic 
spectrum immediately after the chitosan addition 
and after 15 weeks in standard environmental 
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conditions (Figure 1C). Photothermal properties were 
evaluated by measuring the temperature increase 
upon irradiation at three light intensities (Figure 1D). 
A temperature increase of 17.3°C after 120 s was recorded 
at the intensity of 1 W cm−2, not far from that, 19°C, 
reported by Madsen [19] and Zhang [24] for a colloid 
synthesized as ours but subsequently refined depriving it 
of the spherical GNPs and irradiated  with the same light 
intensity.
Alternatively, the photothermal figure of merit 
of a colloidal solution can be suitably described by the 
molar heating rate (MHR) [27] which is defined as the 
temperature growth rate divided by the molar concentration 
of Au. In our case, the best fitting of the temperature 
kinetic recorded at 1 Wcm−2 NIR intensity (Figure 1D), 
gives an initial growth rate of 0.2°C s−1. Dividing this 
rate by the Au molar concentration of 1.4 × 10−3 M, 
a MHR of 143°C s−1 M−1 is derived.
EcFc vs. A375: Au enrichment and 
photothermal properties 
To support the potential translational value of 
ECFCs as vehicles of ChAumix for thermoablation therapy 
Figure 1: nanoparticle characterization. (A) TEM image of Aumix, (b) spectrum of as-synthesized Aumix before (black) and 
after (red) chitosan capping, (c) From the left to the right: z potential of nanoparticles before and after chitosan addition. Spectrum of as-
prepared chitosan capped Aumix (red) and after 15 weeks (purple) (d) From the left to the right: thermography of the NIR-sensitive colloids 
during irradiation; the dashed circle in the thermography corresponds to the well containing the irradiated sample. Kinetics of temperature 
increases at three different light intensities. The straight lines are only a guide for the eye. The red line superimposed to the kinetic recorded 
at 1 W cm−2 is the best fit curve calculated to obtain the molar heating rate (MHR,) of the colloid (see text). The calculated initial growing 
rate is 0.2°C s−1. 
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we measured the ability to accumulate Au nanoparticles 
in ECFCs. Typical results of TEM analysis of the 
enrichment of ECFCs are illustrated in Figure 2A. First, 
the images show that, regardless of the different shapes 
or dimensions, all the populations of GNPs, are equally 
well internalized and mainly packed in phagosomes, 
without introducing cellular damage for both Aumix and 
ChAumix. Second, the density of packed nanoparticles 
is clearly higher in the case of ChAumix, and is 
consistent with a higher internalization likely due to their 
electrostatic attraction which enhances nanoparticle-cell 
membrane interaction. On the basis of these qualitative but 
nonetheless unambiguous findings, we selected ChAumix 
to load ECFCs. Exposure of ECFCs to increasing Au-
mass concentration of 50, 100, 150 µM for 24 h, (from 
now on we refer to either ECFCs or A375 exposed to 
50, 100, 150 µM Au as ECFCs (50, 100, 150) and A375 
(50, 100, 150) resulted in a dose-dependent cellular uptake 
as observed even with a conventional optical microscope 
under white light illumination. Figure 2B clearly shows 
the internalized metal loads into ECFCs, identifiable as 
the black areas inside the cells. ICP-AES confirmed the 
qualitatively observed dose-dependent metal enrichment, 
with the results reported in Figure 2C. Remarkably high 
Au loadings have been found: 50 pg/cell, 100 pg/cell, 
220 pg/cell for ECFCs(50), ECFCs(100) and ECFCs(150) 
respectively. Then, we irradiated Au-rich ECFCs to assess 
their photothermal behavior and evaluating their MHR, 
reported in Figure 2D together with the MHR of the as-
prepared colloid. Noticeably, the MHR of the enriched 
cells, typically 1400°C s−1 M−1, is roughly 7-fold that of 
ChAumix in colloidal solution. This result is in agreement 
with the observation  that closely packed nanoparticles 
behaves as improved heat generators [28], which can also 
explain the good heating performances found by Kang et 
alii [29], obtained by aggregating spherical nanoparticles 
via pH-induced modification of the nanoparticles surface 
electrical charge. In that case, from the data presented, 
a cellular MHR of 1190°C s−1 M−1 can be inferred, quite 
close to the MHR calculated for ECFCs.
The advantage of the improved cellular uptake 
induced by the positively charged nanoparticles could 
also be in principle exploited to enrich the tumor mass 
with a direct inoculation of nanoparticles. For this reason, 
we tested in vitro the A375 capability to incorporate 
ChAumix and warm up upon NIR irradiation. The effects 
have been directly compared with those obtained with 
ECFCs(100), with the results shown in Figure 3. The 
difference in Au-load is already evident at the optical 
microscope analysis, (Figure 3A), but can be fully 
appraised by inspecting the ICP-AES results (Figure 
3B), where ECFC(100) Au content, 100 pg/cell, comes 
out to be 23 times higher than 4.4 pg/cell of A375(100) 
cells. A similar enrichment, 7.9 pg/cell, was found for 
A375(150) cells. The marked difference in the gold 
uptake between A375 and ECFCs produces better thermal 
behavior in the latter case, as it will be shown in the 
subsequent NIR-irradiation tests performed on liquid PBS 
(Phosphate Buffered Saline) suspensions of Au-doped 
A375 and ECFCs (Figure 3C). The thermal kinetics of 
the two suspensions (not reported) allowed us to calculate 
their MHR, that resulted higher (4500°C s−1 M−1 ) 
for A375 than for ECFCs (1400°C s−1 M−1). However 
MHR  does not take into account  the loss of the large 
part of gold particles in the A375 uptake  nor the effects 
of  strong packing, as in the case of ECFCs. It is  well 
known [28, 30] that strong nanoparticles packing reduces 
the interparticles distances producing a shift of the 
absorbance spectrum with a consequent loss of infrared 
light absorption per each particle and a reduction of the 
MHR. Luckily, the reduced MHR of ECFCs is widely 
balanced by the huge uptake of gold nanoparticles by the 
cells so that the heat power produced by enriched ECFCs 
is much higher, and, as a consequence, much higher 
temperatures can be reached in tumors.
Flow cytometry analysis of the fluorescence 
retained by viable cells confirmed that A375(100) and 
unloaded A375, exposed to the same NIR intensity, have 
comparable viability (Figure 3D). Conversely, the viability 
of ECFCs(100) showed a decrease close to 80% compared 
with ECFCs treated just with the vehicle (Figure 3D). 
These results indicate a clear correlation between the 
lower Au-uptake of A375 and the lower temperature raise 
while proving at the same time that Au-loaded ECFCs very 
efficiently absorb NIR light and warm up the surrounding 
medium well beyond the hyperthermic threshold. 
EcFcs phenotypical features vs. Au enrichment
A sufficient intracellular ChAumix uptake, not 
compromising the viability and motility of ECFCs, is a 
critical issue. Hence we examined the incremental dose 
uptake profile along with cytotoxic and biological assay. 
ECFCs were incubated with increasing doses of ChAumix 
for 24 h and measurements of cell viability were conducted 
using WST1 (data not shown) or trypan blue assay as 
described in the Experimental Section. As shown in 
Figure 4A, ChAumix treatment does not affect cell 
morphology and does not reduce the number of viable cells. 
To further evaluate likely effects of GNPs on biological or 
functional cell activities, loaded and unloaded ECFCs were 
induced to capillary morphogenesis. As shown in Figure 
4B ECFCs loaded with ChAumix were capable to form 
capillary network structures with the same effectiveness 
as untreated ECFCs and the degree of differentiation was 
then quantified as number of branching points. These 
results not only show that the Au-enrichment does not 
affect the ECFCs capability to differentiate in tubular-like 
structures, but also that gold nanoparticles are retained 
inside the cells after having been induced to differentiate. 
Since armed ECFCs will be used as cellular vehicles to 
deliver therapeutic GNPs to the tumor site, we further 
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investigated whether nanoparticles uptake could affect 
cell migration. To this purpose ChAumix treated ECFCs 
were used for Boyden chamber assay. This Au-enrichment 
slightly increased the number of migrated cells compared 
to untreated ECFCs (Figure 4C). As we previously found 
that ECFCs home to tumor site by exploiting the CXCR4/
SDF1 axis, we determined whether the presence of 
ChAumix was able to alter CXCR4 expression. ECFCs 
treated for 48 h with 100 µM and 150 µM Au-colloids 
showed significant increase of CXCR4 protein levels 
(Figure 4D). These results reveal the ability of ChAumix 
to modulate the expression of genes involved in cell 
motility such as CXCR4. Indeed, unexpectedly, we found 
a significant upregulation of CXCR4 expression, and a 
sensible increase of cell migration indicating an enhanced 
tumor tropism of Au enriched cells. To investigate the 
Figure 2: AunP EcFc uptake. (A) The uptake of uncapped (left side) and chitosan-capped (right side) Aumix by ECFCs. The 
nanoparticles are endocytosed and enclosed in phagosomes. A lower number of internal gold-rich phagosomes are observed for bare 
nanoparticles, with a lower packing density. (b) The effective endocytosis of ChAumix at increasing concentrations of Au in the incubation 
solution is easily observed also with an optical microscope on non-stained (upper images) or May-Grunwald Giemsa stained (lower images) 
samples. The inner gold content is represented by the black areas in the cells. (c) Dose-dependence of the cells enrichment resulting from 
ICP-AES measurements, (d) molar heating rates (MHR) of an as-made colloidal solution and Au-enriched ECFCs illuminated with the 
same light intensity (3 Wcm−2). For this test, 5 × 104 ECFCs were used after the enrichment stage as described in the Experimental Section. 
P.c. refers to pure colloid (1.4 mM Au molar concentration).
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possible role of SDF-1/CXCR4 axis in ECFC migration, 
we performed a cell migration assay in presence of 
SDF1α ligand. In agreement with previously published 
evidence, the results showed that CXCR4, mediates the 
migration of these cells toward SDF1α, and notably Au 
loaded cells exhibited a greater chemotactic response to 
SDF1α compared with vehicle treated-ECFCs (Figure 4E). 
More importantly, the in vitro cell viability assay showed 
that the nanoparticles were harmless for ECFCs even at 
relatively high concentration suggesting that they might be 
appropriate photothermal agent in cancer therapy. 
In vitro killing of tumor cells by Au-rich EcFcs
We assessed definitely the photothermal potentials 
of Au-enriched ECFCs by proving in vitro the effective 
thermolysis of undoped A375 cells by mixing them with 
ECFCs in a PBS environment with a 20:1 (A375 : ECFCs) 
ratio. 1 × 106 CFSE stained A375 cells were mixed with 
5 × 104: a) vehicle-treated ECFCs, b) ECFCs (100), c) 
ECFCs (150), then the mixtures were irradiated with 
NIR laser light (808 nm wavelength, intensity: 3 Wcm−2). 
Figure 5A shows the thermographic images of cell 
Figure 3: EcFc vs. A375: Au enrichment and photothermal properties. (A) Images of A375 and ECFCs exposed to a 100 μM Au 
colloid and (b) the ICP-AES comparison of the respective Au-cargos. ECFCs are able to uptake an Au mass roughly 23-fold that one 
uptaken by A375 cells. (c) Thermographs of solutions of 1.5 × 105Au-rich A375 cells (left) and an equal number of Au-rich ECFCs (right), 
irradiated with a 3 W cm−2 NIR laser (808 nm wavelength). In the former case, the maximum temperature (41°C) is reached after 6 minutes 
and doesn’t exceed the hyperthermic value, while this is easily obtained for Au-rich ECFCs, that reach a temperature of 70°C after only 
3 minutes of irradiation. (d) The viability of exposed ECFCs strongly reduced after the irradiation.
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Figure 4: EcFc phenotypical features vs. Au enrichment. (A) Cytotoxicity of gold nanoparticles after 24 h exposure on ECFCs: 
on the upper panel, morphological evaluation by bright field microscopy, on the bottom histogram representing viable cells (trypan blue-
negative) counted with the aid of a Burker chamber, as described in Experimental Section. (b) ECFCs treated either with the vehicle 
or with increasing dose of ChAumix were cultured on Matrigel matrix supports. Cell organization was examined microscopically 
(a detailed enlarged structure is shown in the inset) taking random photomicrographs after 24h with the aid of a Nikon E 4500 photo camera 
(Nikon) on a Nikon TMS-F phase contrast microscope (Nikon Instruments) and quantified by manually counting the number of branching 
points/field reported as percent of control ( ECFCs treated with the vehicle). Experiments have been performed three times in triplicate 
with analogous results. (c) Migration of ECFCs treated as in (B) was determined by Boyden chambers, as described in Experimental 
section. Data are expressed as means of migrated cells ± SD of three independent experiments performed in triplicate. (d) Western blotting 
detection of CXCR4 in ECFCs treated as in B) and GAPDH expression, as a control for protein loading. Histograms on the right report 
band densitometry, assuming 1 as the reference value of vehicle treated cells. (E) Migration of ECFCs treated as in (B) and in presence of 
100 ng/ml of SDF1α, was determined by Boyden chambers, as described in Experimental section. Data areexpressed as means of migrated 
cells ± SD of three independent experiments performed in triplicate.
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suspensions after 6 minutes of irradiation. The temperature 
profiles for differently doped ECFCs show that 
hyperthermic regimes are reached for both mixtures, with 
maximum temperatures of 47°C and 65°C for ECFCs(100) 
and ECFCs(150) respectively, while the control mixture 
(A375+vehicle-treated ECFCs) didn’t exceeded 37°C 
temperature. The flow cytometry analysis shows that NIR 
light irradiation of the A375 : ECFCs mixture caused a 
massive loss of A375 viability. In particular, 50% of 
melanoma cells were killed in presence of ECFCs(100), 
while almost a complete A375 loss was achieved with 
ECFCs(150) (Figure 5B). Morphologic examination after 
May-Grunwald staining confirmed the massive loss of 
viable cells, characterized by membrane disruption and 
cellular swelling induced by NIR exposure (Figure 5A).
These tests definitely show in vitro that heavily 
Au-doped ECFCs are able to warm up very efficiently 
tumor environment, and to kill unloaded cancer cells via 
hyperthermic heating.
In vivo photothermal ablation of tumor tissue 
with Au-rich EcFcs 
Taking advantage on in vitro tests, we performed 
preliminary measurements to evaluate the in vivo 
photothermal potentials of Au-laden ECFCs. A mixture of 
1.5 × 106 viable A375 cells were injected into 8 weeks 
old CD-1 nude (nu/ mice) together with 3 × 105 Au-rich 
ECFCs (100 pg/cell) or vehicle treated ECFCs. After the 
tumors reached a volume of 100 mm3, they were exposed 
to an 808 nm laser at a power density of 1 Wcm-2. The 
surface temperature was monitored during irradiation via 
a FLIR thermocamera, while the temperature monitoring 
at a depth of ~ 6 mm is performed with a thermocouple 
gauge. Figure 6A shows the thermographic images of 
tumor mass after 12 seconds and 6 minutes of irradiation. 
The temperature kinetics for the tumor with doped ECFCs 
show that  hyperthermic temperatures are obtained both at 
the surface (50°C) and in depth (45°C) respectively, while 
in presence of unloaded ECFCs tumors didn’t exceeded 
39°C temperature (Figure 6B). Mice were sacrificed one 
week after the last NIR dose exposure and histological 
examinations of tumor tissues from group of mice injected 
with Au-enriched ECFCs confirmed the successful 
destruction of tumor cells due to the photothermal effect 
(Figure 6C). According to hematoxylin and eosin (H&E) 
staining results, common features of thermonecrosis such 
as loss of nucleus, cell shrinkages, and coagulation were 
found in tumor tissues from mice with Au-doped ECFCs 
and exposed to NIR, while viable cells with no obvious 
thermal damage in vehicle plus NIR treated group were 
comparable to No NIR group.
The gold amount found in tumor and RES organs 
such as spleen, kidneys and liver was measured with ICP-
AES (Figure 6D). Noticeably, the gold amount in the 
analyzed RES organs is negligible and this means that, 
during the tumor growth, no significant gold loss occurred. 
Although other experiments are necessary to understand 
these findings, they seem to indicate, as previously 
reported [22], that the interaction of ECFCs through 
CXCR4 with SDF1 of tumor cells is strong enough. At 
the same time, as gold can in principle be exocytosed 
and drained out of the tumor, the above findings point to 
exclude this occurrence, in agreement with the resistance 
to exocytosis of chitosan-capped nanoparticles just 
previously observed for chitosan-capped iron-oxide 
nanoparticles [31].
 From the best fitting of the temperature increase 
of the gold-enriched tumor mass (Figure 6B), a heating 
rate of 0.54°C s−1 is calculated. Considering the molar 
concentration of the Au mass in the tumor volume, a MHR 
of 252°C s−1M−1 is derived. This value might be compared 
with the one inferred from data of Li et alii [32],   that 
injected in the tumor a gold mass of 105 mg. A heating 
rate of 0.16°C s−1 can be inferred from the presented data, 
corresponding to a MHR of 64°C s−1 M−1, that is 3.8 times 
lower than that found for Au-laden ECFCs.
dIscussIon
Anticancer drugs encounter several challenges to 
their therapeutic efficacy, including short half-life, drug 
resistance, and nonspecific distribution with potential 
side effects to healthy organs. Nanotechnology provides 
a powerful tool to circumvent these hurdles and result in 
improved efficacy. Even though during the last decade 
multifunctional nanoparticles (NPs) have been developed 
and modified to elongate circulation time and improve 
the accumulation of therapeutic drugs in tumor tissues, 
the massive uptake of NPs by tumor tissues is still a 
significant challenge. More than 90% of the injected NPs, 
in vivo, end up in or near normal tissues and organs such 
as liver, kidneys and spleen. Use of cells with tumor-
homing capacity for delivery of nanomedicines is a 
relatively new and appealing approach in cancer therapy. 
In a recent study, Kang and coworkers [29] demonstrated 
that harnessing of MSCs as delivery vehicles of gold 
nanospheres led to 4-fold increase in tumor accumulation 
compared with intravenous injection of free nanoparticles. 
Although these results are promising, the biodistribution 
study still showed a low efficacy of tumor targeting 
after intravenous administration and hence the need to 
reduce their off-target accumulation and improve tumor 
tropic features. Moreover, though MSC phenotype can 
be accurately controlled within in vitro settings, it is 
challenging to control cell properties after transplantation 
because MSCs are at the mercy of the biological milieu. 
For instance, MSC immunosuppressive properties 
observed in vitro often do not correlate with in vivo 
function [33, 34].
In this work we show that Au-enriched ECFCs 
are suitable for human melanoma cellular photothermal 
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therapy. ECFCs have the capacity to home, invade, 
migrate within, and incorporate into tumor structures. 
Moreover, ubiquitously available autologous blood 
is conveniently procured, can be easily expanded and 
does not induce immunological intolerance problems. 
For these reasons, ECFCs have been recently elicited 
as ideal candidates for tumor cell therapy [21, 22]. We 
have proved that they can be massively loaded with NIR-
absorbing chitosan-capped nanoparticles without losing 
their phenotypical features. Rather, quite unexpectedly, 
we found a significant increase of CXCR4 expression 
along with a greater migration of Au enriched cells toward 
SDF1α. Moreover, the nanoparticles mix that we used has 
been prepared with a simple one-step protocol without 
Figure 5: Photothermal effects of AunPs on melanoma cells. (A) (Left side) Thermographic images of the liquid mixtures of 
unloaded A375 and unloaded ECFCs or ECFCs(100,150), irradiated with a 808 nm wavelength laser source at the intensity of 4.8 W cm−2. 
While the temperature of the mixtures of unloaded cells doesn’t raise significantly, hyperthermic regimes are reached when ECFCs 
(100,150) are present, reaching maximum temperatures of 47°C and 65°C, for the two enrichments respectively. Correspondent massive 
cells death is observed (right side) with microscope inspection and (b) confirmed by flow cytometry analysis of melanoma cells.
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the use of capping agents or pre-formed seeds and then 
stabilized with chitosan, a highly biocompatible and cheap 
polysaccharide widely used, for instance, in food industry. 
In spite of the inherent lack of homogeneity in the shapes/
dimensions of the produced GNPs, these colloids contain a 
considerable number of NIR-absorbing nanoparticles that 
prove effective in heat production. Other kinds of popular 
NIR-tuned single-shaped GNPs, like Au-nanorods and Au-
nanostars, show higher MHRs [27] about 7-fold higher as, 
for instance, in the favorable case of nanohexapods [32]. 
However, the better performances of purified ChAumix 
and of other NIR-tuned GNPs are paid with non-trivial 
issues in their preparation (i.e. multi-steps procedures, 
lossy purification steps, use of toxic surfactants). As a final 
Figure 6: Photothermal ablation of human melanoma xenograft with Au-rich EcFcs. (A) Thermographic images of the 
irradiated tumors treated with ChAumix-enriched EFCFs (upper part) or vehicle (lower part) and (b) the corresponding  temperature 
growth measured with the FLIR thermocamera (red  points) and with a temperature gauge (dashed black lines), placed at approximately 
6 mm below the skin surface. The continuous red lines represent the exponential best fits of the experimental data. The initial growth rate 
of the upper curve, used to evaluate the MHR of the tumor-hosted Au-enriched ECFCs (see text), is 0.54°C s−1. Upper traces: temperature 
increase of the tumor treated with ChAumix-enriched ECFCs and with vehicle ECFCs (lower traces). (c) Histological Assessments of 
tumor tissues before and after NIR irradiation (1 W cm−2). (Pink: cytoplasm stained with eosin, Dark blue: nuclei stained with hematoxylin) 
(d) Gold amount in liver, spleen and kidney normalized to that one found in tumor mass.
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remark, if from one side the presence of broadly dispersed 
ChAumix limits the absorption at a given excitation 
wavelength to a restricted number of tuned particles, on 
the other side the absorbance remains higher than the 90% 
of the maximum value in a wide band (~ 100 nm), and 
thus may comply more easily with laser users, hopefully 
in hospital. We measured Au loadings as high as 220 pg/
cell, a cell enrichment that, at our knowledge, has not been 
reached so far [2, 29, 32]. This is due to the high efficiency 
of the enriching process, likely driven by the attractive 
forces between positively charged Au nanoparticles and 
negatively charged cells membranes in agreement with 
the observations reported by M. Pérez-Hernández [35]. 
Our findings show for the first time differential uptake 
between human melanoma and ECFC cells exposed 
to the same kind colloid at equal Au concentrations, 
confirming that, besides the complexity of the EPR effect 
and tumor heterogeneity, tumor cells have lower ability to 
accumulate gold in the cancer tissues compared to ECFCs 
and are thus more resistant to cell death induced by NIR 
exposure. Based on these results we can speculate that 
systemic administration of free ChAumix, in vivo will not 
be taken efficiently by tumor cells. Of note Au enrichment 
of A375 cells are of the same order of the highest ones 
reported for other kinds of tumor cells, that span in a wide 
range (from ~10-3 to ~10 pg/cell) [36–39] because of  the 
multiplicity of factors that influence the GNPs uptake. It is 
worth noticing that the highest reported values of ~10 pg/
cell [39] refer to Au-nanorods and chitosan-capped Au-
nanostars, a circumstance that once more seems to confirm 
the increased GNP-cell membrane interaction due to the 
cationic decoration of nanoparticles.
After having been incorporated by ECFCs, chitosan-
capped nanoparticles are closely packed in endosomes, so 
they can benefit of the efficient automatism that prevent 
their ejection from the cells via the lysosomal exocytic 
pathway, as clearly proved for chitosan-capped iron-oxide 
nanoparticles [31].
Both in vitro and in vivo tests have shown the 
excellent thermotransductive properties of enriched 
ECFCs and their ability to kill cancer cells at moderate 
NIR light intensities (in vivo: 1 Wcm−2). At our knowledge, 
we can favorably compare the heating performances of 
Au-rich ECFCs only with the data reported by Li et al. 
[32]; in such case, the MHR of Au-rich ECFCs is clearly 
higher. Based on these findings, doped ECFC might 
be triggered to induce death of tumor cells in vivo.The 
therapeutic impact of these results are relevant for the 
control of melanoma, which is one of the most aggressive 
skin cancer, notorious for its high multidrug resistance, 
easy to relapse and low survival rate.
As ECFCs have been found to avoid the 
accumulation in RES organs and specifically locate 
within tumors, the future opportunity of targeting enriched 
vectors via bloodstream seems a reasonable task. In this 
case, labeled cells with magnetic resonance imaging 
contrast agents, such as iron oxides super-paramagnetic 
nanoparticles (SPIONs) or gadolinium, can work as 
diagnostic probes used in nuclear medicine or optical 
imaging. Thus, a new “theranostic” strategy based on 
specific enriched ECFCs might help clinicians to contrast 
tumor progression and early metastases.
MAtErIALs And MEtHods
cell lines
 Endothelial Colony-Forming-Cells (ECFCs), 
a subpopulation of EPCs, were isolated from > 50 ml 
human umbilical cord blood (UCB) of healthy newborns, 
as described in [40] after maternal informed consent and 
in compliance with Italian legislation, and analyzed for 
the expression of surface antigens (CD45, CD34, CD31, 
CD105, ULEX, vWF, KDR, uPAR) by flow-cytometry. 
The melanoma cell line A375 was obtained from American 
Type Culture Collection (Manassas, VA) and grown in 
Dulbecco’s modified Eagle’s medium (DMEM) with 10% 
FBS (Euroclone).
Preparation and characterization of chAumix
Gold nanoparticles were prepared by chemical 
reduction of HAuCl4, following the recipe of [24]. 
Basically, 3 mM Na2S2O3 solution was added to 1.7 mM 
HAuCl4 solution and vortexed for 20 seconds at room 
temperature. The molar ratio was adjusted in order to 
obtain a plasmonic band close to 800 nm. The solution was 
then left to react undisturbed and the extinction spectrum 
was checked via UV-Vis absorption spectroscopy. The 
colloidal solution was then stabilized by adding a 1% 
acetic acid solution of chitosan (Au/chitosan molar 
ratio = 5) and incubated overnight with gentle shaking. 
Apart from the mandatory sterilization procedure with 
standard autoclave treatments before biological tests, 
the colloid wasn’t subjected to further handling. The 
final Au concentration in the colloidal solutions was 1.4 
mM equivalent to a mass concentration of 280 mg/mL. 
Ultrapure Millipore water (resistivity 18 MW × cm) MilliQ 
water was used as solvent. The sample ChAumix solution, 
used to verify with UV-Vis spectroscopy the nanoparticles 
capping, was purified from chitosan excess by 
centrifugating 2 mL of the prepared solution at 10000 rpm 
for 5 minutes. The surnatant was then removed and the 
remaining colloid was resuspended in ultrapure water and 
used for spectroscopic tests. Tetrachloroauric(III) acid 
(HAuCl4) and thiosulphate (Na2S2O3) were purchased 
from Sigma Aldrich and used as received. High-molecular 
weight chitosan (~106 Da; 79% deacetylation degree) was 
obtained from Heppe Medical. All glassware was cleaned 
with piranha solution (H2SO4 : H2O2 3:1 v/v).
The UV-Vis analysis of the fabricated colloids was 
performed by illuminating a 2 mL liquid sample (optical 
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thickness: 2 mm) placed in a quartz cuvette with a couple 
of deuterium and halogen lamps (Avantes Avalight-DH-
S-BAL), and by recording the absorbance spectra with 
an Avanspec-3648 spectrometer. The z-potential of the 
colloidal solutions was measured with a Malvern Zetasizer 
Nanoseries apparatus. The morphology and dimensions of 
the nanoparticles were checked with a Philips CM12 cryo-
Gatan UHRST 500 @ 100 kV transmission electronic 
microscope (TEM). The sample was prepared by dropping 
the colloidal solutions onto carbon-coated Cu grids and 
letting them dry.
tEM analysis of Au-enriched EcFcs
The ECFCs were seeded in 6-well plates at a density 
of 1.5 × 105 cells per well and allowed to attain 70% 
confluence. The cells were then incubated with a culture 
medium (2 mL per well) containing diluted Au-colloidal 
solutions at a concentration of 50 µM. The cells were 
collected by trypsin treatment after 24 h of incubation, and 
centrifuged at 1000 rpm for 5 min in a 1.5 mL Eppendorf 
tube. The cell pellet was then fixed in isotonic 4% 
glutaraldehyde and 1% OsO4, dehydrated, and embedded 
in Epon epoxy resin (Fluka, Buchs, Switzerland) for 
electron microscopic studies. Ultrathin sections were 
stained with aqueous uranyl acetate and alkaline bismuth 
subnitrate, viewed and photographed under a JEM 1010 
transmission electron microscope (Jeol, Tokyo, Japan) 
equipped with a MegaView III high-resolution digital 
camera and imaging software (Jeol).
Inductively coupled plasma atomic emission 
spectroscopy (IcP-AEs)
The ECFCs were seeded in 6-well plates at a 
density of 1.5 × 105 cells per well and then incubated with 
a culture medium (2 mL per well) containing ChAumix 
at increasing concentrations 50, 100 and 150 µM 
for 24 h. The cells were then washed 2 times with 
phosphate buffered saline (PBS, Invitrogen), detached 
with a trypsin treatment and the cell number was counted 
using a hemocytometer. The cell pellets were collected 
by centrifugation, lyophilized, and placed in centrifuge 
tubes (one pellet per tube). Then 400 µL of aqua regia 
were added to each tube to completely dissolve the cells 
and their gold content. The amount of Au was measured 
by Elan DRC II ICP-MS (Perkin Elmer, Waltham, MA).
cell viability determination 
The viability of ECFCs was determined by i) 
trypan blue staining and ii) cell proliferation assay using 
WST-1 reagent (Roche). Cells (1.5 × 105) were seeded in 
6-well plates and allowed to attach overnight. On the next 
day Au colloidal solutions were added at the indicated 
concentrations. 24 h later 20 µL of cells was aseptically 
transferred to a 1.5 mL clear Eppendorf tube and incubated 
for 3 min at room temperature with an equal volume of 
0.4% (w/v) trypan blue solution prepared in 0.81% NaCl 
and 0.06% (w/v) dibasic potassium phosphate. Viable 
and nonviable cells (trypan blue positive) were counted 
separately using a dual-chamber hemocytometer and a 
light microscope. The means of three independent cell 
counts were pooled for analysis. WST-1 is a water-soluble 
sulfonated tetrazolium salt that is cleaved by cellular 
succinate-dehydrogenases in living cells, yielding dark 
blue formazan. Damaged or dead cells exhibit reduced or 
no dehydrogenase activity. Briefly, cells were seeded into 
the wells of a 96-well plate at a density of 5 × 104 cells 
per well, incubated with AuNPs at various concentrations 
for 24 h. 10 µL of WST-1 in PBS was added to each well, 
and incubated at 37°C for 1 h. Absorbance at 450 nm 
(reference at 630 nm) was measured by a Multiskan JX 
microplate reader.
capillary morphogenesis 
In vitro capillary morphogenesis was performed 
as described in [41] in tissue culture wells coated 
with Matrigel. Cultures were pre-treated with/without 
nanoparticles (50–150 µM) for 24 h and then aliquots 
of ECFCs (1.8 × 104) were plated in EBM-2 medium, 
supplemented with 2% FCS and incubated at 37°C-5% 
CO2. Morphogenesis was evaluated taking pictures at 
different times with the aid of a Nikon E 4500 photocamera 
(Nikon) on a Nikon TMS-F phase-contrast microscope 
(Nikon Instruments). Six to nine photographic fields from 
three plates were scanned for each point. Results were 
quantified by manually counting the number of networks 
branching out from a branch point/node per field expressed 
as percentage in respect to control set as 100%.
Invasion assay
The Boyden chambers were used to evaluate 
spontaneous and stimulated invasion (chemoinvasion) 
of cells through Matrigel-coated 13mm diameter 
polycarbonate filters with 8 μm–pore size. Matrigel 
(BD, Biosciences ) was diluted to the desired final 
concentration (50 μg/filter) with cold distilled water, 
applied to the filters, dried under a hood, and reconstituted 
with serum-free medium. ECFCs were pre-treated with/
without nanoparticles (50–150 µM) for 24 h and then 
aliquots of cells (2 × 104) were resuspended in EBM-
2 medium containing 2% of FBS and placed in the 
upper compartment of the chamber. For assessment of 
spontaneous invasion, same medium was added to the 
lower compartment.  For assessment of chemoinvasion, 
100 ng/ml of SDF1α was dissolved in EBM-2 containing 
2% of FBS and placed in the lower wells. After 6 h 
incubation at 37°C in a humidified atmosphere containing 
5% CO2, the filters were recovered, cells on the upper 
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surface mechanically removed while cells adhered to the 
lower filter surface were fixed with absolute methanol and 
stained with Diff-Quick staining solution. The number of 
cells moving across the filter was used as the measure of 
mobilization. Cells were counted in a double-blind manner 
in five different microscopic fields for each condition with 
a light microscope. All experiments were performed three 
times in triplicate. Migration has been expressed as the 
mean ± SD of the number of total cells counted per well.
Western blot analysis
 Harvested cells were resuspended in 20 mM 
RIPA buffer (pH 7.4) containing a cocktail of proteinase 
inhibitors (Calbiochem, Merck, Darmstadt, Germany) 
and treated by sonication (Microson XL-2000, Minisonix, 
Farmingdale, NY, USA). Proteins were assayed by the 
BCA Protein Assay (Thermo Scientific, Rockford, IL, 
USA), analyzed by SDS-PAGE and western blotting. 
Membranes were probed with primary antibodies against: 
CXCR4 (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) anti-GAPDH (mAbcam 9484) as loading control. 
Suitable peroxidase-conjugated IgG preparations (Sigma-
Aldrich) have been used as secondary antibodies; the ECL 
procedure was employed for development.
Photothermal properties of the chAumix colloid 
 150 mL of the produced colloid (optical density = 0.7) 
were placed into one well of a 96-wells plate, and were 
irradiated with a CW-operating laser diode emitting at 
808 nm wavelength with three different light intensities, 
namely 0.5, 1, 2 W cm−2. Laser light was delivered through 
a multimode optical fiber and collimated in a spot size of 
5 mm diameter. The temperature raise was monitored 
during the irradiation with a thermocamera FLIR B335 
(Spectral range 7.5–13 mm, sensitivity: 50 mK) equipped 
with a 18 mm focal length objective and a field of view 
(FOV) of 25° × 19° and recorded each 2 minutes. The 
images were elaborated with InfraRecorder software 
(version 0.52.0.0).
In vitro photothermal treatment of Au-enriched 
cells and A375:EcFcs stoves mixture
To evaluate cell damage induced by NIR exposure, 
cells were labelled with carboxyfluorescein diacetate 
succinimidyl ester dye (Cell Trace CFSE; Molecular Probe, 
LifeTtechnology) which easily cross the plasma membrane 
and covalently binds to amine groups in proteins, resulting 
in long-term dye retention within the cell.
In a first test, we compared the photothermal 
behavior of Au-loaded A375/ECFCs. Cells were treated 
for 24 h with 100 µM ChAumix. After 24 h incubation, the 
growth medium was removed and the cells were washed 
several times with PBS to remove the free ChAumix that 
were not taken up by the cells. The cells were subsequently 
subjected to trypsin treatment and labeled with CFSE to 
evaluate the effect of cell loss after NIR exposure. 150 µl 
of cell suspension composed by 1.5 × 105 of CFSE 
stained A375 treated with vehicle or with ChAumix or by 
1.5 × 105 of CFSE-stained ECFCs treated with vehicle 
or ChAumix were exposed to a CW NIR light laser at 
808 nm (4.8 W cm−2) for 6 minutes. After laser exposure, 
the fluorescence retained by viable cells was measured 
by flow cytometry. In the cocolture experiment 150 µl of 
cell suspension composed by 1.0 × 106 of  CFSE stained 
A375 were mixed either with 5 × 104  vehicle-treated 
ECFC or with AuNPs loaded ECFC and were exposed to 
a continuous red light laser at 808 nm (4.8 W cm−2) for 
6 minutes. After laser exposure, the fluorescence retained 
by A375 viable cells was measured by flow cytometry. 
Morphological changes were microscopically examined 
either by phase contrast or methanol-fixed cells stained 
with May-Grunwald using a Digital Camera System 
Leica DC 200 (Leica Microsystems, Inc. Bannockburn, 
IL, USA). 
In vivo photothermal treatment of tumors 
All in vivo procedures were approved by the ethical 
committee of Animal Welfare Office of Italian Work 
Ministry and conformed to the legal mandates and Italian 
guidelines for the care and maintenance of laboratory 
animals. Six- to eight-week-old female athymic nude mice 
were purchased from Charles River. Evaluation of the 
therapeutic local effect of Au-laden ECFCFs on the tumor 
onset, were performed by co-injecting 1.5 × 106 A375 
cells in the flank of nude mice together with 0.3 × 106 
vehicle treated ECFCs (4 mice) or Au-laden ECFC 
(6 mice). In order to determine tumor volume, the greatest 
longitudinal diameter (length) and the greatest transverse 
diameter (width) were determined with external caliper. 
Tumor volume based on caliper measurements were 
calculated by the following formula; tumor volume = 
length × width2 × 0.5. Tumors reaching approximately 
100 mm3 in volume were selected for the study. During 
the procedure, mice were anesthetized with isoflurane. The 
vehicle-treated mice group and the AU-laden ECFCs were 
exposed to NIR light three times each other day. During 
heating, thermal images were collected for mice before 
heating, and at 12 seconds, 1, 2, 3, 4, 5 and 6 minutes into 
the heating process. Throughout heating, the temperature 
of the tumors was monitored by thermocamera FLIR B335 
as previously described. To prove that the effect on tumor 
was due to hyperthermia one group of tumor bearing mice 
inoculated with Au-doped ECFCs were not exposed to 
NIR irradiation. The animals were monitored daily and 
were sacrificed one week after the last NIR treatment. 
The histological analysis of tumor mass was performed 
as described below.  Removed tumors and RES organs 
were fixed overnight at 4°C in formalin (5% in PBS) for 
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histological analysis performed on paraffin-embedded 
sections (6 µm). The sections of tumor tissue was stained 
using hematoxylin and eosin and examined using an 
optical microscope.
To quantify the amount of gold in the tumor and 
organs, resected mouse tissues were prepared and analyzed 
using ICP-MS. Samples were frozen in liquid nitrogen 
and weighed, then digested in aqua regia and prepared as 
previously described.
statistical analysis
Statistical analysis was performed using 1 
way ANOVA, Bonferroni post hoc test (**P < 0.01, 
***P < 0.001). Independent experiments were performed 
at least 3 times in triplicate. Graphical representations 
were performed using GraphPad Prism version 5 
(GraphPad Software, San Diego, CA).
AcknoWLEdgMEnts And FundIng
Financial support by Ente Cassa di Risparmio di 
Firenze and Associazione Italiana Ricerca sul Cancro 
(AIRC), grant IG 2013 N. 14266 (MDR) are gratefully 
acknowledged. Dr. Anastasia Chillà was supported by 
a post-doctoral fellowship of the Federazione Italiana 
Cancro. The authors also thank Dr. Stefano Sottini for his 
helpful comments and suggestions and Mr. Saverio Priori 
for the assistance in the in vivo test.
conFLIcts oF IntErEst
The Authors state no conflicts of interest.
rEFErEncEs
 1. Christie C, Madsen SJ, Peng Q, Hirschberg H. Macrophages 
as nanoparticle delivery vectors for photothermal therapy of 
brain tumors. Therapeutic Delivery. 2015; 6:371–384.
 2. Mooney R, Roma L, Zhao D, Van Haute D, Garcia E, Kim SU, 
Annala AJ, Aboody KS,  Berlin JM. Neural stem cell-
mediated intratumoral delivery of gold nanorods improves 
photothermal therapy. ACS Nano. 2014; 8:12450–12460.
 3. Huang X, Zhang F, Wang H, Niu G, Choi KY, 
Swierczewska M, Zhang G, Gao H, Wang Z, Zhu L, 
Choi HS, Lee S, Chen X. Mesenchymal stem cell-based 
cell engineering with multifunctional mesoporous silica 
nanoparticles for tumor delivery. Biomaterials. 2013; 
34:1772–1780.
 4. Patel SK, Janjic JM. Macrophage targeted theranostics as 
personalized nanomedicine strategies for inflammatory 
diseases. Theranostics 2015; 5:150–172.
 5. Ahmad MZ, Akhter S, Rahman Z, Akhter S, Anwar M, 
Mallik N, Ahmad FJ. Nanometric gold in cancer 
nanotechnology: current status and future prospect. J. 
Pharm. Pharmacol. 2013; 65:634–651.
 6. Cobley CM, Au L, Chen J, Xia Y. Targeting gold nanocages 
to cancer cells for photothermal destruction and drug 
delivery. Expert Opin. Drug Delivery. 2010; 7:577–587.
 7. O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. 
Photo thermal tumor ablation in mice using near infrared 
absorbing nanoparticles. Cancer Lett. 2004; 209:171–176.
 8. Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, 
Kanazawa S. Radiofrequency ablation as treatment for 
pulmonary metastasis of colorectal cancer. World J. 
Gastroenterol. 2014; 20:988–996.
 9. Wang L, Ge M, Xu D, Chen L, Qian C, Shi K, Liu J, Chen YJ. 
Ultrasonography-guided percutaneous radiofrequency 
ablation for cervical lymph node metastasis from thyroid 
carcinoma. J. Cancer Res. Ther. 2014; 10:C144.
10. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y. 
Engineered nanoparticles for drug delivery in cancer 
therapy. Angew. Chem., Int. Ed. 2014; 53:12320–12364.
11. Clementi F, Palade GE. Intestinal capillaries. II. Structural 
effects of EDTA and histamine. J. Cell Biol. 1969; 
42:706–714.
12. Sarin HJ. Physiologic upper limits of pore size of different 
blood capillary types and another perspective on the dual 
pore theory of microvascular permeability. Angiog. Res. 
2010; 2:14.
13. Longmire M, Choyke PL, Kobayashi H. Clearance 
properties of nano-sized particles and molecules as imaging 
agents: considerations and caveats. Nanomedicine. 2008; 
3:703–717.
14. Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X, Tang LH, 
Zheng BJ, Yuen KY, Smith DK, Song E, Huang JD. Explicit 
hypoxia targeting with tumor suppression by creating an 
“obligate” anaerobic Salmonella Typhimurium strain. Sci. 
Rep. 2012; 2:436.
15. He Z, Liu J, Du L. The unexpected effect of PEGylated 
gold nanoparticles on the primary functions of erythrocites. 
Nanoscale. 2014; 7:9017–9024.
16. El-Sayed MA, Shabaka AA, El-Shabrawy OA, Yassin NA, 
Mahmoud SS, El-Shenawy SM, Al-Ashqar E, Eisa WH, 
Farag NM, El-Shaer MA, Salah N, Al-Abd AM. Tissue 
distribution and efficacy of gold nanorods coupled with 
laser induced photoplasmonic therapy in ehrlich carcinoma 
solid tumor model. PLoS One. 2013; 8:e76207. 
17. Chithrani DB, Dunne M, Stewart J, Allen C, Jaffray DA. 
Cellular uptake and transport of gold nanoparticles 
incorporated in a liposomal carrier. Nanomedicine. 2010; 
6:161–169.
18. Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, 
Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, 
Bashir R, Halas NJ, Clare SE. A cellular Trojan Horse for 
delivery of therapeutic nanoparticles into tumors. Nano 
Lett. 2007; 7:3759–3765.
Oncotarget39860www.impactjournals.com/oncotarget
19. Madsen SJ, Baek SK, Makkouk AR, Krasieva T, 
Hirschberg H. Macrophages as Cell-Based Delivery 
Systems for Nanoshells in Photothermal Therapy. Ann. 
Biomed. Eng. 2012; 40:507–515.
20. Choi MR, Bardhan R, Stanton-Maxey KJ, Badve S, 
Nakshatri H, Stantz KM, Cao N, Halas NJ, Clare SE. 
Delivery of Nanoparticles to Brain Metastases of Breast 
Cancer Using a Cellular Trojan Horse. Cancer Nanotechnol. 
2012; 3:47–54. 
21. Bieback K, Vinci M, Elvers-Hornung S, Bartol A, Gloe T, 
Czabanka M, Klüter H, Augustin H, Vajkoczy P. 
Recruitment of human cord blood-derived endothelial 
colony-forming cells to sites of tumor angiogenesis. 
Cytotherapy. 2013; 15:726–739.
22. Laurenzana A, Biagioni A, D’Alessio S, Bianchini F, Chillà A, 
Margheri F, Luciani C, Mazzanti B, Pimpinelli N, Torre E, 
Danese S, Calorini L, Del Rosso M, et al. Melanoma cell 
therapy: Endothelial progenitor cells as shuttle of the 
MMP12 uPAR-degrading enzyme.  Oncotarget. 2014; 
5:3711–3727. doi: 10.18632/oncotarget.1987.
23. Wei J, Blum S, Unger M, Jarmy G, Lamparter M, 
Geishauser A, Vlastos GA, Chan G, Fischer KD, Rattat D, 
Debatin KM, Hatzopoulos AK, Beltinger C. Embryonic 
endothelial progenitor cells armed with a suicide gene target 
hypoxic lung metastases after intravenous delivery. Cancer 
Cell. 2004; 5:477–488.
24. Zhang G, Sun X, Jasinski J, Patel D, Gobin AM. Gold/
Chitosan Nanocomposites with Specific Near Infrared 
Absorption for Photothermal Therapy Applications. J. 
Nanomater. 2012, article ID 853416.
25. Zhang G, Jasinsky JB, Howell JL, Patel D, Stephans DP, 
Gobin AM. Tunability and stability of gold nanoparticles 
obtained from chloroauric acid and sodium thiosulfate 
reaction.  Nanoscale Res. Lett. 2012; 7:337.
26. Zhang G, Jazinsky JB, Patel D, James K, Sun X, Gobin AM. 
Near Infrared Tunable Gold Nanoparticles for Low Power 
Laser Ablation of Esophageal Adenocarcinoma. MRS 
Online Proc. Libr. 2012; 1416:37.
27. Wang X, Li G, Ding Y, Sun S. Understanding the 
photothermal effect of gold nanostars and nanorods for 
biomedical applications. RSC Adv. 2014; 4:30375–30383.
28. Govorov AO, Richardson HH. Generating Heat with Metal 
Nanoparticles. NanoToday. 2007; 2:30–38.
29. Kang S, Bhang SH, Hwang S, Yoon JK, Song J, Jang HK, 
Kim S, Kim BS. Mesenchymal Stem Cells Aggregate and 
Deliver Gold Nanoparticles to Tumors for Photothermal 
Therapy. ACS Nano. 2015; 9:9678–9690.
30. Su KH, Wei QH, Zhang X. Interparticle coupling effects 
on Plasmon resonances of nanogold particles. Nano Lett. 
2003; 3:1087–1090.
31. Bakhru SH, Altiok E, Highley C, Delubac D, Suhan J, 
Hitchens TK, Ho C, Zappe S. Enhanced cellular uptake 
and long-term retention of chitosan-modified iron-oxide 
nanoparticles for MRI-based cell tracking. Int. J. Nanomed. 
2012; 7:4613–4623.
32. Li Z, Huang H, Tang S, Li Y, Yu XF, Wang H, Li P, Sun Z, 
Zhang H, Liu C, Chu PK. Small gold nanorods laden 
macrophages for enhanced tumor coverage in photothermal 
therapy. Biomaterials. 2016; 74:144–154.
33. François M, Galipeau J. New insights on translational 
development of mesenchymal stromal cells for suppressor 
therapy. J. Cell Physiol. 2012; 227:3535–3538.
34. Von Bahr L, Sundberg B, Lönnies L, Sander B, Karbach H, 
Hägglund H, Ljungman P, Gustafsson B, Karlsson H, 
Le Blanc K, Ringdén O. Long-term complications, 
immunological effects, and role of passage for outcome 
in mesenchymal stromal-cell therapy. Biol. Blood Marrow 
Transplant. 2012; 18:557–564.
35. Pérez-Hernández M, Del Pino P, Mitchell SG, Moros M, 
Stepien G, Pelaz B, Parak WJ, Gálvez EM, Pardo J, de 
la Fuente JM. Dissecting the Molecular Mechanism of 
Apoptosis during Photothermal Therapy Using Gold 
Nanoprisms. ACS Nano. 2015; 9:52–61.
36. Au L, Zhang QM, Cobley C, Gidding M, Schwartz AG, 
Chen J, Xia Y. Quantifying the cellular upatzke of antibody-
conjugated Au nanocages by two photon microscopy and 
inductively coupled plasma mass spectroscopy. ACS Nano. 
2010; 4:35–42.
37. Huang JH, Lai TC, Cheng LC, Liu RS, Lee CH, Hsiao M, 
Chen CH, Her LJ, Tsai DP. Modulating cell-uptake behavior 
of Au-based nanomaterials via quantitative biomolecule 
modification. J. Mater. Chem. 2011; 21:14821–14829.
38. Wang Y, Black KCL, Luehmann H, Li W, Zhang Y, Cai X, 
Wan D, Liu SY, Li M, Kim P, Li ZH, Wang LV, Liu Y, et al. 
Comparison study of gold nanohexapods, nanorods, and 
nanocages for photothermal cancer treatment. ACS Nano. 
2013; 7:2068–2077.
39. Baginskiy I, Lai TC, Cheng LC, Chan YC, Yang KY, 
Liu RS, Hsiao M, Chen CH, Hu SF, Her LJ, Tsai DP. 
Chitosan modified stable colloidal gold nanostars for the 
photothermolysis of cancer cells. J. Phys. Chem. C.  2013; 
117:2396–2410.
40. Margheri F, Chillà A, Laurenzana A, Serratì S, Mazzanti B, 
Saccardi R, Santosuosso M, Danza G, Sturli N, Rosati F, 
Magnelli L, Papucci L, Calorini L, et al. Endothelial 
progenitor cell-dependent angiogenesis requires localization 
of the full-length form of uPAR in caveolae. Blood. 2011; 
118:3743–3755.
41. Laurenzana A, Cencetti F, Serratì S, Bruno G, Japtok L, 
Bianchini F, Torre E, Fibbi G, Del Rosso M, Bruni P, 
Donati C. Endothelial sphingosine kinase/SPNS2 axis is 
critical for vessel-like formation by human mesoangioblasts. 
J. Mol. Med. 2015; 93:1145–1157.
